![Tausif Butt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Tausif Butt currently works at Navigator Medicines, Inc., as Chief Executive Officer from 2025.
Mr. Butt also formerly worked at AstraZeneca PLC, as Senior Vice President-Latin America from 2019 to 2021, ChemoCentryx, Inc., as Chief Operating Officer & Executive Vice President from 2021 to 2022, and Idorsia Pharmaceuticals US, Inc., as President & General Manager.
Mr. Butt received his graduate degree from Imperial College London and undergraduate degree from the University of Brighton.
Posizioni attive di Tausif Butt
| Società | Posizione | Inizio |
|---|
Precedenti posizioni note di Tausif Butt
| Società | Posizione | Fine |
|---|---|---|
| CHEMOCENTRYX, INC. | Direttore operativo | 20/10/2022 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2021 |
Idorsia Pharmaceuticals US, Inc. | Presidente | - |
Formazione di Tausif Butt
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
14
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Brighton
 University of Brighton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Idorsia Pharmaceuticals US, Inc. | Health Technology |
